These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7413726)

  • 21. Proceedings: The link between the mother and fetus in drug metabolism.
    Feuer G
    Rev Can Biol; 1973; 32():Suppl:113-21. PubMed ID: 4798225
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics in the ovine maternal-fetal unit.
    Szeto HH
    Annu Rev Pharmacol Toxicol; 1982; 22():221-43. PubMed ID: 7044285
    [No Abstract]   [Full Text] [Related]  

  • 23. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of pharmacokinetics in realizing the embryotoxic action of drugs].
    Smol'nikova NM; Boĭko SS; Liubimov BI
    Farmakol Toksikol; 1986; 49(2):106-11. PubMed ID: 3519275
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug kinetics in childbirth.
    Nation RL
    Clin Pharmacokinet; 1980; 5(4):340-64. PubMed ID: 6994980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drugs during preeclampsia. Fetal risks and pharmacology].
    Serreau R; ; ; ;
    Ann Fr Anesth Reanim; 2010 Apr; 29(4):e37-46. PubMed ID: 20347563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical effects of pharmacologic agents on pregnancy, the fetus, and the neonate.
    Finnegan L
    Ann N Y Acad Sci; 1976; 281():74-89. PubMed ID: 798531
    [No Abstract]   [Full Text] [Related]  

  • 28. The placenta and placental transfer of drugs at term.
    Abouleish E
    Pa Med; 1975 May; 78(5):56-62, 68-74. PubMed ID: 1093102
    [No Abstract]   [Full Text] [Related]  

  • 29. A rat model for the study of transplacental pharmacokinetics and its assessment with antipyrine and aminoisobutyric acid.
    Varma DR; Ramakrishnan R
    J Pharmacol Methods; 1985 Aug; 14(1):61-74. PubMed ID: 4033137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Placental transfer of drugs].
    Evain-Brion D; Berveiller P; Gil S
    Therapie; 2014; 69(1):3-11. PubMed ID: 24698183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of fetal drug concentrations.
    Anderson DF; Phernetton TM; Rankin JH
    Am J Obstet Gynecol; 1980 Jul; 137(6):735-8. PubMed ID: 7395939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contributions of the ex vivo human perfused placenta in the study of placental transfer of drugs].
    Ceccaldi PF; Mandelbrot L; Farinotti R; Forestier F; Gil S
    J Gynecol Obstet Biol Reprod (Paris); 2010 Dec; 39(8):601-5. PubMed ID: 20692775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care.
    Pinheiro EA; Stika CS
    Semin Perinatol; 2020 Apr; 44(3):151221. PubMed ID: 32115202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug transfer and metabolism by the human placenta.
    Syme MR; Paxton JW; Keelan JA
    Clin Pharmacokinet; 2004; 43(8):487-514. PubMed ID: 15170365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of morphine and methadone disposition in the maternal-fetal unit.
    Szeto HH; Umans JG; McFarland J
    Am J Obstet Gynecol; 1982 Jul; 143(6):700-6. PubMed ID: 7091244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dosage and adverse effect problems in pregnancy].
    Kuemmerle HP
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):356-9. PubMed ID: 5148893
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
    Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications.
    DeVane CL
    NIDA Res Monogr; 1995; 149():116-29. PubMed ID: 8775838
    [No Abstract]   [Full Text] [Related]  

  • 39. Environmental influences on human foetal and placental xenobiotic metabolism.
    Pelkonen O
    Eur J Clin Pharmacol; 1980 Jul; 18(1):17-24. PubMed ID: 7398743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of drug transfer across the human placenta-a workshop report.
    St-Pierre MV; Ugele B; Gambling L; Shiverick KT
    Placenta; 2002 Apr; 23 Suppl A():S159-64. PubMed ID: 11978077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.